Neuroprosthetic therapies may enable spinal injury patients to walk

02/18/2013 | Innovations-Report.com

Swiss scientists are developing neuroprosthetic technologies designed to restore voluntary locomotion control to patients with severe spinal cord injuries. Grégoire Courtine, of the École Polytechnique Fédérale de Lausanne, expects to begin clinical human trials within the next two years. He detailed his study, which used a robotic harness and electrochemical stimulation to restore movement in paralyzed rats, and described what's ahead at a recent scientific meeting in Boston.

View Full Article in:

Innovations-Report.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC